Could CannTrust (TSX:TRST) Face Criminal Charges?

CannTrust Holdings Inc. (TSX:TRST)(NYSE:CTST) is facing more than just a license suspension as the company could have legal problems to deal with as well.

office buildings

Image source: Getty Images

CannTrust Holdings Inc. (TSX:TRST)(NYSE:CTST) recently submitted its official response to Health Canada in relation to violations that the regulator found at its Pelham, Ontario location.

Now, the company must wait for a decision while Health Canada makes a decision on what to do next. As a spokesman from Health Canada said that it wouldn’t hesitate to take action that would protect the public, it doesn’t sound like the regulator is going to be doing CannTrust any favours.

Looming criminal charges?

While one of the major concerns facing CannTrust today is whether the company will have its license suspended, that’s not the only problem the company may have to worry about.

If it’s true that CannTrust was growing in rooms where it hadn’t yet been authorized to do so, then those acts could be in violation of the Cannabis Act.

Illegal cannabis activity could be charged criminally and the penalties for that could range from fines to imprisonment of up to 14 years.

Any company facing those kinds of problems is one that investors should stay away from. SNC-Lavalin is a good example of how legal problems can send a stock reeling.

Ultimately, it will boil down to whether Health Canada sends its findings to the police. And at this point, there’s no indication that the regulator is going to go easy on CannTrust.

Although the repercussions for the industry could be significant, the government has made it clear that safety has been a priority for the new industry, and having companies growing pot in unlicensed rooms jeopardizes that trust.

If the allegations prove to be true, the most damning evidence against the company could be that it was making fake walls in order to mislead Health Canada. That would demonstrate intent and I’d be surprised if regulators wouldn’t come down hard under those circumstances.

What does this mean for investors today?

CannTrust’s stock is still very fragile, and with it losing so much value over the past couple of weeks, some may be tempted to buy it and roll the dice in hopes the company will be able to emerge relatively unscathed.

However, there’s still a lot of potential downside for the stock, especially if Health Canada decides to suspend the company’s license and charges are laid against the company.

At that point, CannTrust would have little, if any, value left. It’s a risky proposition to be an investor right now, as there’s a very real possibility that if you’re holding CannTrust shares you could still lose a significant amount of your investment — or what’s left of it.

While there’s definitely potential for the stock to jump if Health Canada simply gives the company a fine, given the attention this issue has garnered and all the eyeballs on it, it’s not a scenario that I’d bet on happening.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor David Jagielski has no position in any of the stocks mentioned.

More on Cannabis Stocks

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Are Cannabis Stocks Still a Thing in 2023?

The whole question of whether cannabis stocks are still relevant in 2023 is an interesting one. Here's my take on…

Read more »

A cannabis plant grows.
Cannabis Stocks

Why Canopy Growth Stock Fell 72% Last Year

Canopy Growth stock is a beaten-up cannabis giant that is trading at a discount compared to historical multiples. But is…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is SNDL Stock a Buy in January 2023?

SNDL is among the worst-performing cannabis stocks in the last three years. But is SNDL stock a buy right now?

Read more »

a person watches a downward arrow crash through the floor
Cannabis Stocks

Why Tilray Stock Fell Almost 60% in 2022

Tilray is a Canadian cannabis stock that is down 93% from all-time highs. Let's see if TLRY stock is a…

Read more »